Skip to main content
Samir Parekh, MD, Oncology, New York, NY, The Mount Sinai Hospital

SamirSunilParekhMD

Oncology New York, NY

Hematologic Oncology

Associate Professor, Hematology/Oncology and Oncological Sciences, Icahn School of Medicine at Mount Sinai

Overview of Dr. Parekh

Dr. Samir Parekh is an oncologist in New York, NY and is affiliated with The Mount Sinai Hospital. He received his medical degree from KJ Somaiya Medical College and has been in practice 18 years. Dr. Parekh accepts several types of health insurance, listed below. He is one of 191 doctors at The Mount Sinai Hospital who specialize in Oncology. He has more than 100 publications and over 500 citings.

Education & Training

  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2002 - 2005
  • Cook County Health and Hospitals System
    Cook County Health and Hospitals SystemResidency, Internal Medicine, 1999 - 2002
  • KJ Somaiya Medical College
    KJ Somaiya Medical CollegeClass of 1999

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2005 - 2025
  • IL State Medical License
    IL State Medical License 1999 - 2005
  • American Board of Internal Medicine Hematology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Minimal Residual Disease (MRD) Assessment in the ECOG1411 Randomized Phase 2 Trial of Front-Line Bendamustine-Rituximab (BR)-Based Induction Followed By Rituximab (R) ...
    Samir Parekh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • High Dimensional Immune Profiling in Smoldering Multiple Myeloma Identifies Novel Organizing Features of the Tumor Microenvironment
    Samir Parekh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Targeting Hypersumoylation in Mantle Cell Lymphoma
    Samir Parekh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Increased HLA-E Expression Correlates with Early Relapse in Multiple Myeloma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Development of a Neoantigen Prediction Tool for Patient Stratification in Immuno-Oncology Trials 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Myeloma Patients Who Relapse After CAR T-cell Therapy Have Options
    Myeloma Patients Who Relapse After CAR T-cell Therapy Have OptionsNovember 4th, 2022
  • Therapy Options for Multiple Myeloma Patients Who Relapse Upon Immunotherapy
    Therapy Options for Multiple Myeloma Patients Who Relapse Upon ImmunotherapyNovember 4th, 2022
  • Novel Approach Brings Hospice-Bound MM Patient into Remission
    Novel Approach Brings Hospice-Bound MM Patient into RemissionSeptember 29th, 2022
  • Join now to see all

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    Anthem Blue Access PPO
    Anthem Blue Preferred HMO
    BCBS Blue Card PPO
    BCBS Illinois PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    First Health PPO
    GHI PPO
    Great West PPO
    Healthfirst New York
    HIP of New York - Select PPO
    Humana ChoiceCare Network PPO
    MagnaCare PPO
    Multiplan PHCS PPO
    Multiplan PPO
    Oxford Health Freedom
    Oxford Health Liberty
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment